Upsher-Smith Laboratories

Upsher-Smith Laboratories, LLC is an American pharmaceutical company based in Maple Grove, Minnesota. Founded in 1919, it has been owned by Bora Pharmaceuticals since 2024.

Upsher-Smith Laboratories
Company typeSubsidiary
IndustryPharmaceuticals
Founded1919 (1919) in Wayzata, Minnesota, U.S.
HeadquartersMaple Grove, Minnesota, U.S.
Key people
Products
Parent
  • Sawai Group Holdings Co.
  • (2017–24)
  • Bora Pharmaceuticals
  • (2024–present)
Websitewww.upsher-smith.com

History

Founded in 1919 as a maker of digitalis drugs,[3] Upsher-Smith has traditionally focused on the manufacture of generic medications.

In 2017, after owning it for 47 years, the Evenstad family decided to sell most of the firm, the generics business, to Sawai Group Holdings Co., Ltd., a large publicly traded generics company in Japan that had been seeking entry into the U.S. market.[4] Its non-generic pharmaceutical business, Proximagen, Pairnomix, and MOBĒ, remained with ACOVA, a holding company owned by the Evenstads.

On April 1, 2024, Upsher-Smith Laboratories was acquired by Bora Pharmaceuticals Co., Ltd., considered the largest pharmaceutical manufacturer in Taiwan.[5]

Locations

Products

Upsher-Smith offers brand and generic pharmaceuticals to treat the following disease states:[7]

References
  1. "Taku Nakaoka Named CEO of Upsher-Smith Laboratories".
  2. "Executive Team".
  3. "Upsher-Smith History".
  4. "Sawai Pharmaceutical Completes Acquisition of Upsher-Smith Laboratories Generics Business". May 31, 2017.
  5. "Bora Pharmaceuticals Completes the Acquisition of Upsher-Smith". Upsher-Smith. Retrieved 2024-04-04.
  6. "Locations – Upsher-Smith". Upsher-Smith Laboratories, LLC. Retrieved 2022-06-21.
  7. "Upsher-Smith Products".
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.